Archives: Speakers

His medical training as a specialist in orthopaedics and trauma surgery laid the foundation for his current entrepreneurship. The accuracy and the knowledge of how to acquire new knowledge helped him daily in the challenges as an entrepreneur. Since 2012, he has been dedicated to developing vegan cheese alternatives. Mudar started Happy Cheeze as a Limited back in 2016. In the meantime, they have grown as a team of 40 employees based in Cuxhaven – the passion has remained with them, and demand has continued to grow. 2017 they opened a new production facility in Cuxhaven – where they are able to produce more than 300,000 products monthly and ship them to foodies from all over the world. Although they have expanded, they still rely on traditional production methods and loving craftsmanship in their manufacturing – you can taste it in every bite! Due to the growing demand, Happy Cheeze is already looking forward to expanding again in the near future.

Anita is the founder and CEO of a Manchester/Ibiza based beverage start-up Crave Drinks. Prior to that she was the Category Manager, Vegan and Organic for a leading sport nutrition company Myprotein. She is a passionate and engaged leader with advanced degrees from Stockholm University and Peking University, Guanghua School of Management.

A communication/marketing professional with several years experience working within retail and for a global brand company delivering internal/external communication projects and driving corporate branding. Maria started her career in the drinks industry working with premium drink brands including Absolut, Malibu and Kahlua at The Absolut Company in Stockholm, Sweden. Since leaving Pernod Ricard in 2015 she has worked with expansion communication and PR For IKEA and with several entrepreneurial projects. Early 2017, Maria (Swedish) and her husband Craig (South African) discovered a magical valley, home to many intriguing botanicals, in the Cederberg mountains, just north of Cape Town. The valley, which they now co-own, inspired them to distil rare Cape & classic gin botanicals, and then blend with pristine Swedish water. The result is CEDER’S, a distilled non-alcoholic alt-gin, your Everyday Escape.

Flemming Morth is Head of Center of Innovation at Royal Swinkels Family Brewers, known for its iconic brands like Bavaria 0.0, PALM, 8.6, Cornet and Habesha. He is responsible for building a strong innovation pipeline, improving time to market, fostering and commercializing new growth opportunities. He graduated from Aalborg University in Denmark with a Master’s degree in International Business. Flemming has successfully developed and launched innovations, new brands and new business models in various industries. He is passionate about rethinking marketing and innovation to help customers better achieve their goals.

Farooq Hussain is the Regional Director Europe for Avantor Clinical Services. Working with customers across the region to improve their clinical trial effectiveness and efficiencies, through providing scalable, end-to-end service capabilities, including biorepository and sample management, custom kitting, and clinical trial equipment & ancillary solutions. Farooq has over two decades of experience in the pharmaceutical sector, both for pharma companies in a variety of commercial roles as well as working for service providers to the industry. He earned his BSc in Biological Sciences from Nottingham Trent University.

Sinead is a Digital Healthcare and Clinical Research Executive with a career spanning clinical care, academic research and digital health across multiple therapeutic areas including oncology, internal medicine and vaccines development. She joins THREAD with over 18 years’ experience in clinical service delivery, sponsor research governance, CRO and eHealth. Sinead oversees the Delivery team in the EMEA as the executive sponsor for customer portfolios within THREAD. Sinead is a clinically trained radiotherapist with a bachelor’s degree from the School of Medicine, Trinity College Dublin and a Master of Science clinical research from the University of London.

Roger has 30 years of management and drug development expertise from his leading roles in preclinical and clinical drug development programs, regulatory strategy and interactions, funding, and outsourcing to specialist service providers. With his experience in basic research, large and small pharma, and CRO settings he provides valuable insight into business and R&D operations for pharma/biotech companies. His specific therapeutic areas of expertise are in diabetes, oncology, gene therapy, and cardiovascular indications. He is currently President and Co-Founder at BioKier and was previously CEO at Plakous Therapeutics and Senior Scientist in Clinical Development at Cato Research. Roger received a PhD in Pharmacology and Biochemistry from Melbourne University and completed Postdoctoral fellowships at the National Institute of Environmental Health Sciences and at Burroughs Wellcome.

Currently leading Clinical Operations at Tenax Therapeutics, Kevin M. Crawford is a 23-year clinical research veteran, having held leadership posts under such leading brands as GlaxoSmithKline (GSK), Johnson & Johnson, and United Therapeutics. A certified executive coach, contributing writer and vlogger as well, Kevin’s insights on a personal and professional mission, organizational leadership and life balance have garnered a growing cult following and demand as an executive consultant and speaker. With a Master’s degree in Biotechnology from the University of Maryland, he has published in the Journals of the American Thoracic Society and American College of Chest Physicians. Kevin lives in Raleigh, NC with his wife and three children, and when he is not “ON,” he enjoys playing soccer, kayaking, volunteering and having bad coffee with good friends